Font Size: a A A
Keyword [after Percutaneous Coronary Intervention]
Result: 61 - 80 | Page: 4 of 10
61. The Relationgship Between Platelet-derived Growth Factor-BB And Restenosis After Percutaneous Coronary Intervention
62. Systematic Study Of Diagnostic Standard Of Traditional Chinese Medicine Syndrome In Coronary Heart Disease Patients After Percutaneous Coronary Intervention
63. Huang Lijuan Academic Thoughts And Clinical Experience And Clinical Research For The Treatment Of Coronary Restenosis After Interventional
64. Myocardial Protective Effect Of Danhong Injection Evaluated By Velocity Vector Imaging In Patients With Unstable Angina Pectoris After Percutaneous Coronary Intervention
65. The Predictive Value Of EuroSCORE Ⅱ To ULMCA Patients After Percutaneous Coronary Intervention
66. Optimal Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
67. Influence Of Danhong Injection Combined External Counterpulsation On The Patients After Percutaneous Coronary Intervention
68. Lipid Profile Analysis Of Patients With Acute Coronary Syndrome In CCU And Its Relationship With Myocardial Perfusion After Percutaneous Coronary Intervention
69. Taking Different Statins6Months Lipid Levels And Cimt Change Analysis On Patients After Percutaneous Coronary Intervention Treatment
70. Effects Of Trans-theoretical-model-based Health Education On Health Behaviors Of Patients After Percutaneous Coronary Intervention
71. The Myocardial Protective Effect Of Nocorandil On Patients With Unstable Angina Pectoris After Percutaneous Coronary Intervention Therapy
72. The Value Of Cystatin C For Predicting Prognosis In Patients With Acute Coronary Syndromes After Percutaneous Coronary Intervention
73. Autoantibodies Against AT1-receptor In Patients With Restenosis After Percutaneous Coronary Intervention
74. Clinical Study Of The Newly Synthesized Buyanghuanwu Decoction On Treating Coronary Heart Disease After Percutaneous Coronary Intervention With Qi Deficiency-blood Stasis Syndrome
75. Clinical Value Of Three-dimensional Visible Coronary Artery Model And New Techniques Of Echocardiography In Quantitative Analysis Of Myocardial Motion And Cardiac Function Before And After Percutaneous Coronary Intervention
76. Impact Of Intensive Statin Use On The Level Of Inflammation, Platelet Activation And The Incidence Of Mace In Patients With Stable Angina After Percutaneous Coronary Intervention
77. Effects Of Different Doses Of Naoxintong Capsule Combined With Dual Antiplatelet Therapy In Patients With Cytochrome P4502C19*2Gene Mutation After Percutaneous Coronary Intervention
78. The Clinical Research On The Preventive And Protective Effect Of Contrast-induced Nephropathy After Percutaneous Coronary Intervention Treatment With Acetylcysteine
79. The Evaluation Study On The Effectiveness Of Chinese Herbal Medicines For Nourishing Qi And Resolving Blood Stasis In The Treatment Of Unstable Angina After Percutaneous Coronary Intervention Based On Markov Model
80. The Study Of Hydration In Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
  <<First  <Prev  Next>  Last>>  Jump to